Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced the AVX-10K Flight Line Test Set has been approved for use on all Boeing commercial aircraft where the IFR4000 and IFR6000 had previously been approved.
ZoomInfo (NASDAQ: ZI) today announced that its Board of Directors approved a share repurchase program authorizing the Company to repurchase, from time to time, up to $100 million of the Company's Common Stock.
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) announced that the composition of matter patent previously allowed by the United States Patent and Trademark Office (USPTO) has now been granted. The patent, entitled "Compounds for and methods of treating diseases" (No. 11,603,364), covers more than 100 novel compounds with an acyl hydrazone (AH) structure and provides 20 years of exclusivity.